Significant issues explored in this article include:

- Mechanism of COX-2 and IP

- PGI2's role in anti-platelet aggregation and preventing thrombosis

- Vasodilatory effects of PGI2 particularly in pulmonary arterial hypertension

- A corresponding increase in COX-1 activity during COX-2 inhibition